September 2015

10th Annual Pennsylvania Chapter Cure SMA Walk-n-Roll Reaches Milestone Year

Leave a Comment / Archives /

Originally published on July 15, 2013. The 10th Annual PA Chapter Cure SMA Walk-n-Roll, held May 19, 2013 at Lloyd Hall Recreation Center in Philadelphia, PA was a tremendous success!  Over 800 “walkers and rollers” turned out for a beautiful day of family fun. Seventeen teams contributed to the success of this year’s walk with […]

10th Annual Pennsylvania Chapter Cure SMA Walk-n-Roll Reaches Milestone Year Read More »

New Update on Clinical Development of RG7800

Leave a Comment / Clinical Trials, Front Page News /

Genentech recently provided an update on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscular atrophy (SMA): “Moonfish is studying RG7800, an investigational SMN2 splicing modifier that Genentech (Roche) is developing for the treatment of spinal muscular atrophy (SMA). This program is in

New Update on Clinical Development of RG7800 Read More »

Scroll to Top